Effects of 3-dimensional Versus Dynamic Myofascial Release Techniques With Lumbar Mobilization and Exercise Therapy Program in Chronic Non-specific Low Back Pain.
NCT07920991, Not applicable, Enrolling by invitation, Riphah International University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of 3-dimensional Versus Dynamic Myofascial Release Techniques With Lumbar Mobilization and Exercise Therapy Program in Chronic Non-specific Low Back Pain. | ClinicalTrials.gov |
| NCT number | NCT07920991 | ClinicalTrials.gov |
| Status | Enrolling by invitation | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 52 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Riphah International University | ClinicalTrials.gov |
| Conditions | Chronic Non-Specific Low Back Pain, Myofascial Release | ClinicalTrials.gov |
| Interventions | 3 Dimensional Myofascial Release, Dynamic Myofascial Release, Lumbar Mobilization, Exercise Therapy Program | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Pain intensity on Numeric Pain Rating Scale (NPRS) | Baseline (pre) and at the 4th Week of Study (post) | Pain intensity will be measured using a numeric rating scale (NRS). Participants will rate their current pain severity using an 11-point pain numerical rating scale ranging from 0 (no pain at all) to 10 (the worst imagined pain). It interpret as 0: No Pain, 1-3: Mild Pain, 4-6: Moderate Pain and 7-10: Severe Pain. | ClinicalTrials.gov |
| Secondary | Lumbar Range of Motions by Goniometer | Baseline (pre) and at the 4th Week of Study (post) | Lumbar ROM will be assessed using a manual goniometer according to standard clinical protocols. Common movements include lumbar flexion (forward bending), extension (backward bending), lateral flexion (side bending), and rotation. The participant should remain in a neutral position for 5 s, then the ROM assessment will be conducted: lumbar flexion, lumbar extension, lumbar lateral flexion, and lumbar rotation. Scientific evidence of normal lumbar flexion (65°), lumbar extension (31°), lateral flexion (30°), and rotation (15.3°). | ClinicalTrials.gov |
| Secondary | Functional Disability in Oswestry Disability Index (ODI) | Baseline (pre) and at the 4th Week of Study (post) | Functional impairment will be measured using the Oswestry Disability Index (ODI). Participants will mark replies in ten categories on a 0-5 scale using the original English ODI version. Scores will be computed as (counted marks/50 × 100%). Mild disability is classified as 0-20%, moderate disability as 21-40%, severe disability as 41-60%, crippled handicap as 61-80%, and total disability as 81-100%. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 5
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)